Merck KGaA: down after Q3 results

(CercleFinance.com) - Merck KGaA is down more than 2% in Frankfurt, despite the publication of EPS adjusted for exceptional items up 11.
1% to 2.30 euros, and adjusted EBITDA up 11.9% to 1.62 billion euros, for the third quarter of 2024.

Its corresponding margin improved by 2.8 points to 30.7% on sales of almost 5.23 billion euros, up 1.8% (+3.8% organic) thanks to positive performances in all three sectors.

The German group reports 'a return to organic sales growth in Life Sciences, solid sales growth and outstanding profitability in Health Care, as well as another quarter of profitable growth in Electronics'.

Merck KGaA confirms its full-year targets, stating that it is heading towards the middle of its target ranges for adjusted EPS (8.20 to 9.30 euros) and EBITDA (5.8 to 6.4 billion), but in the lower half of that for sales (20.7 to 22.1 billion).

Copyright (c) 2024 CercleFinance.com. All rights reserved.